Outcome of Flow Diverters with Surface Modifications in Treatment of Cerebral Aneurysms: Systematic Review and Meta-analysis

References

1. 1.↵
   1. Limbucci N,
   2. Leone G,
   3. Renieri L, et al

   . Expanding indications for flow diverters: distal aneurysms, bifurcation aneurysms, small aneurysms, previously coiled aneurysms and clipped aneurysms, and carotid cavernous fistulas. Neurosurgery 2020;86:S85–94 doi:10.1093/neuros/nyz334 pmid:31838532

   CrossRefPubMed
2. 2.↵
   1. Leung GK,
   2. Tsang AC,
   3. Lui WM

   . Pipeline Embolization Device for intracranial aneurysm: a systematic review. Clin Neuroradiol 2012;22:295–303 doi:10.1007/s00062-012-0178-6 pmid:23124329

   CrossRefPubMed
3. 3.↵
   1. Zhou G,
   2. Zhu YQ,
   3. Su M, et al

   . Flow-diverting devices versus coil embolization for intracranial aneurysms: a systematic literature review and meta-analysis. World Neurosurg 2016;88:640–45 doi:10.1016/j.wneu.2015.11.007 pmid:26585732

   CrossRefPubMed
4. 4.↵
   1. Brinjikji W,
   2. Murad MH,
   3. Lanzino G, et al

   . Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442–47 doi:10.1161/STROKEAHA.112.678151 pmid:23321438

   Abstract/FREE Full Text
5. 5.↵
   1. Briganti F,
   2. Leone G,
   3. Marseglia M, et al

   . Endovascular treatment of cerebral aneurysms using flow-diverter devices: a systematic review. Neuroradiol J 2015;28:365–75 doi:10.1177/1971400915602803 pmid:26314872

   CrossRefPubMed
6. 6.↵
   1. Ye G,
   2. Zhang M,
   3. Deng L, et al

   . Meta-analysis of the efficiency and prognosis of intracranial aneurysm treated with flow diverter devices. J Mol Neurosci 2016;59:158–67 doi:10.1007/s12031-016-0723-x pmid:26816083

   CrossRefPubMed
7. 7.↵
   1. Matsuda Y,
   2. Chung J,
   3. Lopes DK

   . Analysis of neointima development in flow diverters using optical coherence tomography imaging. J Neurointerv Surg 2018;10:162–67 doi:10.1136/neurintsurg-2016-012969 pmid:28592484

   Abstract/FREE Full Text
8. 8.↵
   1. Moher D,
   2. Liberati A,
   3. Tetzlaff J, et al

   ; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535 doi:10.1136/bmj.b2535 pmid:19622551

   FREE Full Text
9. 9.↵
   National Institutes of Health, National Heart, Lung, and Blood Institute. Study Quality Assessment Tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed October 1, 2019
10. 10.↵
    1. Rousseau MJ,
    2. Evans JC

    . Key statistical assumptions and methods in one-arm meta-analyses with binary endpoints and low event rates, including a real-life example in the area of endoscopic colonic stenting. Cogent Medicine 2017;4:13343318 doi:10.1080/2331205X.2017.1334318

    CrossRef
11. 11.↵
    1. Higgins JP,
    2. Thomas J,
    3. Chandler J, et al.

    , eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration and John Wiley & Sons Ltd.; 2011
12. 12.↵
    1. Nyaga VN,
    2. Arbyn M,
    3. Aerts M

    . Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 2014;72:39 doi:10.1186/2049-3258-72-39 pmid:25810908

    CrossRefPubMed
13. 13.↵
    1. Martínez-Galdámez M,
    2. Lamin SM,
    3. Lagios KG, et al

    . Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study. J Neurointerv Surg 2017;9:772–76 doi:10.1136/neurintsurg-2016-012896 pmid:28223428

    Abstract/FREE Full Text
14. 14.↵
    1. Martínez-Galdámez M,
    2. Lamin SM,
    3. Lagios KG, et al

    . Treatment of intracranial aneurysms using the Pipeline Flex Embolization Device with Shield technology: angiographic and safety outcomes at 1-year follow-up. J Neurointerv Surg 2019;11:396–99 doi:10.1136/neurintsurg-2018-014204 pmid:30262655

    Abstract/FREE Full Text
15. 15.↵
    1. Daglioglu E,
    2. Akmangit İ,
    3. Acik V, et al

    . The experience of the Derivo® Embolisation Device in intracranial aneurysms. Turk Neurosurg 2020;30:30–37 doi:10.5137/1019-5149.JTN.25776-19.2 pmid:31049921

    CrossRefPubMed
16. 16.↵
    1. Goertz L,
    2. Dorn F,
    3. Kraus B, et al

    . Improved occlusion rate of intracranial aneurysms treated with the Derivo Embolization Device: one-year clinical and angiographic follow-up in a multicenter study. World Neurosurg 2019;126:e1503–09 doi:10.1016/j.wneu.2019.03.137 pmid:30910748

    CrossRefPubMed
17. 17.↵
    1. Goertz L,
    2. Dorn F,
    3. Kraus B, et al

    . Safety and efficacy of the Derivo Embolization Device for the treatment of ruptured intracranial aneurysms. J Neurointerv Surg 2019;11:290–95 doi:10.1136/neurintsurg-2018-014166 pmid:30082333

    Abstract/FREE Full Text
18. 18.↵
    1. Kraus B,
    2. Goertz L,
    3. Turowski B, et al

    . Safety and efficacy of the Derivo Embolization Device for the treatment of unruptured intracranial aneurysms: a multicentric study. J Neurointerv Surg 2019;11:68–73 doi:10.1136/neurintsurg-2018-013963 pmid:29848557

    Abstract/FREE Full Text
19. 19.↵
    1. Kaschner MG,
    2. Petridis A,
    3. Turowski B

    . Single center experience with the new generation Derivo embolization device for ruptured and unruptured intracranial aneurysms. J Neurosurg Sci 2020;64:353–63 doi:10.23736/S0390-5616.19.04678-2 pmid:31079436

    CrossRefPubMed
20. 20.↵
    1. Owusu MA,
    2. Rice HA,
    3. De Villiers LE, et al

    . SCOPE-AUS: the safety and clinical effectiveness of Pipeline™ Flex Embolization Devices with Shield Technology™ in patients with intracranial aneurysms: a multicentre retrospective study of an Australian cohort. In: Proceedings of the Annual Meeting of the World Federation of Interventional and Therapeutic Neuroradiology, Naples, Italy. December 1–24, 2019
21. 21.↵
    1. Trivelato FP,
    2. Abud DG,
    3. Ulhôa AC, et al

    . Derivo Embolization Device for the treatment of intracranial aneurysms. Stroke 2019;50:2351–58 doi:10.1161/STROKEAHA.119.025407 pmid:31288675

    CrossRefPubMed
22. 22.↵
    1. Trivelato FP,
    2. Wajnberg E,
    3. Rezende MTS, et al

    . Safety and effectiveness of the Pipeline Flex Embolization Device with Shield Technology for the treatment of intracranial aneurysms: midterm results from a multicenter study. Neurosurgery 2020;87:104–11 doi:10.1093/neuros/nyz356 pmid:31504821

    CrossRefPubMed
23. 23.↵
    1. Akgul E,
    2. Onan HB,
    3. Akpinar S, et al

    . The DERIVO Embolization Device in the treatment of intracranial aneurysms: short- and midterm results. World Neurosurg 2016;95:229–40 doi:10.1016/j.wneu.2016.07.101 pmid:27514698

    CrossRefPubMed
24. 24.↵
    1. Atasoy D,
    2. Kandasamy N,
    3. Hart J, et al

    . Outcome study of the Pipeline Embolization Device with Shield Technology in Unruptured Aneurysms (PEDSU). AJNR Am J Neuroradiol 2019;40:2094–2101 doi:10.3174/ajnr.A6314 pmid:31727754

    Abstract/FREE Full Text
25. 25.↵
    1. Fiorella D,
    2. Gache L,
    3. Frame D, et al

    . How safe and effective are flow diverters for the treatment of unruptured small/medium intracranial aneurysms of the internal carotid artery? Meta-analysis for evidence-based performance goals. J Neurointervent Surg 2020;12:869–73 doi:10.1136/neurintsurg-2019-015535 pmid:32005761

    Abstract/FREE Full Text
26. 26.↵
    1. Bhatia KD,
    2. Kortman H,
    3. Orru E, et al

    . Periprocedural complications of second-generation flow diverter treatment using Pipeline Flex for unruptured intracranial aneurysms: a systematic review and meta-analysis. J Neurointerv Surg 2019;11:817–24 doi:10.1136/neurintsurg-2019-014937 pmid:31147438

    Abstract/FREE Full Text
27. 27.↵
    1. Cagnazzo F,
    2. Mantilla D,
    3. Rouchaud A, et al

    . Endovascular treatment of very large and giant intracranial aneurysms: comparison between reconstructive and deconstructive techniques-a meta-analysis. AJNR Am J Neuroradiol 2018;39:852–58 doi:10.3174/ajnr.A5591 pmid:29545248

    Abstract/FREE Full Text
28. 28.↵
    1. Cagnazzo F,
    2. di Carlo DT,
    3. Cappucci M, et al

    . Acutely ruptured intracranial aneurysms treated with flow-diverter stents: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2018;39:1669–75 doi:10.3174/ajnr.A5730 pmid:30049721

    Abstract/FREE Full Text
29. 29.↵
    1. Zhu D,
    2. Yan Y,
    3. Zhao P, et al

    . Safety and efficacy of flow diverter treatment for blood blister-like aneurysm: a systematic review and meta-analysis. World Neurosurg 2018;118:e79–86 doi:10.1016/j.wneu.2018.06.123 pmid:29944999

    CrossRefPubMed
30. 30.↵
    1. Kiyofuji S,
    2. Graffeo CS,
    3. Perry A, et al

    . Meta-analysis of treatment outcomes of posterior circulation non-saccular aneurysms by flow diverters. J Neurointerv Surg 2018;10:493–99 doi:10.1136/neurintsurg-2017-013312 pmid:28965108

    Abstract/FREE Full Text
31. 31.↵
    1. Cebral JR,
    2. Mut F,
    3. Raschi M, et al

    . Aneurysm rupture following treatment with flow-diverting stents: computational hemodynamics analysis of treatment. AJNR Am J Neuroradiol 2011;32:27–33 doi:10.3174/ajnr.A2398 pmid:21071533

    Abstract/FREE Full Text
32. 32.↵
    1. Rouchaud A,
    2. Brinjikji W,
    3. Lanzino G, et al

    . Delayed hemorrhagic complications after flow diversion for intracranial aneurysms: a literature overview. Neuroradiology 2016;58:171–77 doi:10.1007/s00234-015-1615-4 pmid:26553302

    CrossRefPubMed
33. 33.↵
    1. Mitha AP,
    2. Mynard JP,
    3. Storwick JA, et al

    . Can the Windkessel hypothesis explain delayed intraparenchymal haemorrhage after flow diversion? A case report and model-based analysis of possible mechanisms. Heart, Lung Circ 2015;24:824–30 doi:10.1016/j.hlc.2015.02.001 pmid:25804624

    CrossRefPubMed
34. 34.↵
    1. Korkmazer B,
    2. Kocak B,
    3. Islak C, et al

    . Long-term results of flow diversion in the treatment of intracranial aneurysms: a retrospective data analysis of a single center. Acta Neurochir 2019;161:1165–73 doi:10.1007/s00701-019-03912-6 pmid:31037497

    CrossRefPubMed
35. 35.↵
    1. Naggara ON,
    2. White PM,
    3. Guilbert F, et al

    . Endovascular treatment of intracranial unruptured aneurysms: systematic review and meta-analysis of the literature on safety and efficacy. Radiology 2010;256:887–97 doi:10.1148/radiol.10091982 pmid:20634431

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Caroff J,
    2. Tamura T,
    3. King RM, et al

    . Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasia. J Neurointerv Surg 2018;10:1097–101 doi:10.1136/neurintsurg-2018-013776 pmid:29511117

    Abstract/FREE Full Text
37. 37.↵
    1. Chiu AH,
    2. Cheung AK,
    3. Wenderoth JD, et al

    . Long-term follow-up results following elective treatment of unruptured intracranial aneurysms with the Pipeline embolization device. AJNR Am J Neuroradiol 2015;36:1728–34 doi:10.3174/ajnr.A4329 pmid:25999412

    Abstract/FREE Full Text
38. 38.↵
    1. Hanel RA,
    2. Aguilar-Salinas P,
    3. Brasiliense LB, et al

    . First US experience with Pipeline Flex with Shield Technology using aspirin as antiplatelet monotherapy. BMJ Case Rep 2017;2017:bcr2017219406 doi:10.1136/bcr-2017-219406 pmid:28473431

    CrossRefPubMed
39. 39.↵
    1. Orlov K,
    2. Kislitsin D,
    3. Strelnikov N, et al

    . Experience using Pipeline Embolization Device with Shield Technology in a patient lacking a full postoperative dual antiplatelet therapy regimen. Interv Neuroradiol 2018;24:270–73 doi:10.1177/1591019917753824 pmid:29378449

    CrossRefPubMed